Who are Oncolytics Biotech Inc.'s main suppliers?

Oncolytics Biotech Inc. (ONCY) key suppliers include: JEFFERIES-LLC, ALUMNI-CAPITAL-LP, Genelux Corporation. View the full supplier network at chainsifter.com/chain/ONCY.

Who are Oncolytics Biotech Inc.'s major customers?

Oncolytics Biotech Inc. (ONCY) key customers include: PANCREATIC-CANCER-ACTION-NETWORK, Genelux Corporation. View the full customer network at chainsifter.com/chain/ONCY.

What sector is Oncolytics Biotech Inc. in?

Oncolytics Biotech Inc. (ONCY) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ONCY Supply Chain: Oncolytics Biotech Inc. Supplier List & 7 Relationships

3Suppliers

2Customers

2Debt Items

11Related Chains

Oncolytics Biotech Inc. Suppliers

Ticker	Name	Confidence	Evidence
JEFFERIES-LLC	JEFFERIES-LLC	92%	the Company may offer and sell from time to time through or to the agent, acting as agent or principal, shares of the Company’s common stock
ALUMNI-CAPITAL-LP	ALUMNI-CAPITAL-LP	90%	On April 10, 2025, we entered into a standby equity purchase agreement (the “SEPA Arrangement”) with Alumni Capital LP ("Alumni"), as described further in Note 7 of the consolidated financial stateme…
GNLX	Genelux Corporation	72%	Reciprocal relationship from GNLX graph: Reciprocal relationship from ONCY graph: Reciprocal relationship from GNLX graph: Reciprocal relationship from ONCY graph: Reciprocal relationship from GNLX g…

Oncolytics Biotech Inc. Customers

Ticker	Name	Confidence	Evidence
PANCREATIC-CANCER-ACTION-NETWORK	PANCREATIC-CANCER-ACTION-NETWORK	90%	concentration of credit risk consist primarily of cash and cash equivalents and other receivables from the Pancreatic Cancer Action Network
GNLX	Genelux Corporation	72%	Reciprocal relationship from GNLX graph: ials between batches from a single supplier or between suppliers; ● the possible breach by our third-party suppliers and service providers of our agreements w…

Oncolytics Biotech Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ONCY-DEBT-20261	Warrants outstanding: 2.81	90%	xbrl warrant detail from xbrl 2026-03-31.
ONCY-DEBT	Debt stack $563,000	90%	Market cache reports total debt of $563,000.

Oncolytics Biotech Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Oncolytics Biotech Inc..

Oncolytics Biotech Inc. Ownership

Holder	Name	Confidence	Evidence
ONCY-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 60 tracked holders.

Oncolytics Biotech Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
GNLX	Genelux Corporation	100.00	1	['customer', 'supplier']
REGN	Regeneron Pharmaceuticals, Inc.	50.00	2
CADL	Candel Therapeutics, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
TOVX	Theriva Biologics, Inc.	50.00	2
REPL	Replimune Group, Inc.	50.00	2
IOVA	Iovance Biotherapeutics, Inc.	50.00	2
JNJ	Johnson & Johnson	50.00	2
CELG-RI	BRISTOL MYERS SQUIBB CO	50.00	2
LLY	Eli Lilly and Company	50.00	2

Oncolytics Biotech Inc. Supply Chain